Cargando…
Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018
Immune checkpoint inhibitors (CPIs) have radically changed outcomes for patients diagnosed with metastatic melanoma globally in the last 10 years, based on evidence of overall survival (OS) benefits generated from international randomised controlled trials (RCTs). Since RCTs do not always reflect re...
Autores principales: | Board, Ruth, Smittenaar, Rebecca, Lawton, Sarah, Liu, Hanhua, Juwa, Bukky, Chao, David, Corrie, Pippa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821238/ https://www.ncbi.nlm.nih.gov/pubmed/32838478 http://dx.doi.org/10.1002/ijc.33266 |
Ejemplares similares
-
Weight change since age 20 and incident risk of obesity‐related cancer in Japan: a pooled analysis of the Miyagi Cohort Study and the Ohsaki Cohort Study
por: Wakamatsu, Mano, et al.
Publicado: (2018) -
Challenges in assessing the sunscreen‐melanoma association
por: Rueegg, Corina S., et al.
Publicado: (2019) -
Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050
por: Pilleron, Sophie, et al.
Publicado: (2020) -
Risk of breast cancer in men in relation to weight change: A national case‐control study in England and Wales
por: Swerdlow, Anthony J., et al.
Publicado: (2022) -
Incidence and mortality trends of melanoma in Croatia, 1988-2008
por: Barbarić, Jelena, et al.
Publicado: (2012)